FDA issued a Warning Letter to Tubilux Pharma Spa on 7/6/2017 for a previous inspection.
483 Tubilux Pharma Spa Apr 2018

483 Tubilux Pharma Spa Apr 2018

$119 - Not in Stock

FDA investigators audited the Tubilux Pharma Spa - Pomezia, Italy facility and issued inspectional observations (via FDA 483) on 06 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Apr 2018
  • Location: Pomezia, Italy
  • FEI: 3003854110

Pre-Order Not Available